143 related articles for article (PubMed ID: 34293507)
1. Dose characteristics of Au-198 eye brachytherapy applicator: A Monte Carlo study.
Kamrani S; Aghamiri SMR; Hashemi S
Appl Radiat Isot; 2021 Oct; 176():109866. PubMed ID: 34293507
[TBL] [Abstract][Full Text] [Related]
2. Monte Carlo dosimetry of the eye plaque design used at the St. Erik Eye Hospital for (125)I brachytherapy.
Karlsson M; Nilsson J; Lundell M; Carlsson Tedgren A
Brachytherapy; 2014; 13(6):651-6. PubMed ID: 24950821
[TBL] [Abstract][Full Text] [Related]
3. Monte Carlo dosimetry for 125I and 103Pd eye plaque brachytherapy.
Thomson RM; Taylor RE; Rogers DW
Med Phys; 2008 Dec; 35(12):5530-43. PubMed ID: 19175111
[TBL] [Abstract][Full Text] [Related]
4. EyeDose: An open-source tool for using published Monte Carlo results to estimate the radiation dose delivered to the tumor and critical ocular structures for
Deufel CL; McCauley Cutsinger S; Corbin KS; Dalvin LA; Petersen IA
Brachytherapy; 2021; 20(1):189-199. PubMed ID: 33187821
[TBL] [Abstract][Full Text] [Related]
5. A Monte Carlo dose calculation system for ophthalmic brachytherapy based on a realistic eye model.
Miras Del Río H; Ortiz Lora A; Bertolet Reina A; Terrón León JA
Med Phys; 2021 Aug; 48(8):4542-4559. PubMed ID: 34250607
[TBL] [Abstract][Full Text] [Related]
6. Model-based dose calculations for COMS eye plaque brachytherapy using an anatomically realistic eye phantom.
Lesperance M; Inglis-Whalen M; Thomson RM
Med Phys; 2014 Feb; 41(2):021717. PubMed ID: 24506608
[TBL] [Abstract][Full Text] [Related]
7. Dosimetry of (125)I and (103)Pd COMS eye plaques for intraocular tumors: report of Task Group 129 by the AAPM and ABS.
Chiu-Tsao ST; Astrahan MA; Finger PT; Followill DS; Meigooni AS; Melhus CS; Mourtada F; Napolitano ME; Nath R; Rivard MJ; Rogers DW; Thomson RM
Med Phys; 2012 Oct; 39(10):6161-84. PubMed ID: 23039655
[TBL] [Abstract][Full Text] [Related]
8. Monte Carlo dosimetry for 103Pd, 125I, and 131Cs ocular brachytherapy with various plaque models using an eye phantom.
Lesperance M; Martinov M; Thomson RM
Med Phys; 2014 Mar; 41(3):031706. PubMed ID: 24593710
[TBL] [Abstract][Full Text] [Related]
9. A practical method of estimating medium-heterogeneity corrected dose without a Monte Carlo calculation in ocular brachytherapy using
Lee YC; Nik Akhtar M; Kim Y; Jung JW
Brachytherapy; 2024; 23(3):377-386. PubMed ID: 38336557
[TBL] [Abstract][Full Text] [Related]
10. Gold nanoparticle-based brachytherapy enhancement in choroidal melanoma using a full Monte Carlo model of the human eye.
Asadi S; Vaez-zadeh M; Masoudi SF; Rahmani F; Knaup C; Meigooni AS
J Appl Clin Med Phys; 2015 Sep; 16(5):344–357. PubMed ID: 26699318
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of material heterogeneity dosimetric effects using radiochromic film for COMS eye plaques loaded with (125)I seeds (model I25.S16).
Acar H; Chiu-Tsao ST; Ozbay I; Kemikler G; Tuncer S
Med Phys; 2013 Jan; 40(1):011708. PubMed ID: 23298078
[TBL] [Abstract][Full Text] [Related]
12. Experimental validation of a new COMS-like 24 mm eye plaque for the treatment of large ocular melanoma tumors.
McCauley Cutsinger S; Forsman R; Corner S; Deufel CL
Brachytherapy; 2019; 18(6):890-897. PubMed ID: 31444131
[TBL] [Abstract][Full Text] [Related]
13. Monte Carlo dosimetry for 125I and 103Pd eye plaque brachytherapy with various seed models.
Thomson RM; Rogers DW
Med Phys; 2010 Jan; 37(1):368-76. PubMed ID: 20175499
[TBL] [Abstract][Full Text] [Related]
14. A comprehensive dosimetric comparison between (131)Cs and (125)I brachytherapy sources for COMS eye plaque implant.
Zhang H; Martin D; Chiu-Tsao ST; Meigooni A; Thomadsen BR
Brachytherapy; 2010; 9(4):362-72. PubMed ID: 20116342
[TBL] [Abstract][Full Text] [Related]
15. Accurate estimation of dose distributions inside an eye irradiated with 106Ru plaques.
Brualla L; Sempau J; Zaragoza FJ; Wittig A; Sauerwein W
Strahlenther Onkol; 2013 Jan; 189(1):68-73. PubMed ID: 23161122
[TBL] [Abstract][Full Text] [Related]
16. Hydrogen nanobubbles: A novel approach toward radio-sensitization agents.
Hashemi S; Aghamiri SM; Siavashpour Z; Kahani M; Zaidi H; Jaberi R
Med Phys; 2023 Oct; 50(10):6589-6599. PubMed ID: 37278345
[TBL] [Abstract][Full Text] [Related]
17. Dosimetry for 125I seed (model 6711) in eye plaques.
Chiu-Tsao ST; Anderson LL; O'Brien K; Stabile L; Liu JC
Med Phys; 1993; 20(2 Pt 1):383-9. PubMed ID: 8497229
[TBL] [Abstract][Full Text] [Related]
18. Delivered dose changes in COMS plaque-based ocular brachytherapy arising from vitrectomy with silicone oil replacement.
Morrison H; Larocque MP; Menon G; Sloboda RS; Weis E
Brachytherapy; 2019; 18(5):668-674. PubMed ID: 31272841
[TBL] [Abstract][Full Text] [Related]
19. Radiobiology for eye plaque brachytherapy and evaluation of implant duration and radionuclide choice using an objective function.
Gagne NL; Leonard KL; Rivard MJ
Med Phys; 2012 Jun; 39(6):3332-42. PubMed ID: 22755715
[TBL] [Abstract][Full Text] [Related]
20. Comparison of dose calculation methods for brachytherapy of intraocular tumors.
Rivard MJ; Chiu-Tsao ST; Finger PT; Meigooni AS; Melhus CS; Mourtada F; Napolitano ME; Rogers DW; Thomson RM; Nath R
Med Phys; 2011 Jan; 38(1):306-16. PubMed ID: 21361199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
